BARCLAYS PLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 79 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$34,000
-51.4%
70,501
+34.9%
0.00%
Q1 2019$70,000
+250.0%
52,247
+194.0%
0.00%
Q4 2018$20,000
-83.5%
17,769
-59.4%
0.00%
Q3 2018$121,000
+764.3%
43,774
+1029.7%
0.00%
Q2 2018$14,000
-85.6%
3,875
-87.7%
0.00%
Q1 2018$97,000
-77.9%
31,494
-54.6%
0.00%
Q4 2017$438,000
-42.1%
69,441
-37.1%
0.00%
-100.0%
Q3 2017$756,000
+8.9%
110,461
+13.4%
0.00%0.0%
Q2 2017$694,000
-33.5%
97,397
-14.1%
0.00%0.0%
Q1 2017$1,043,000
+666.9%
113,441
+236.7%
0.00%
Q4 2016$136,000
+13500.0%
33,688
+14675.4%
0.00%
Q3 2016$1,000
-50.0%
228
-58.4%
0.00%
Q2 2016$2,000
-96.0%
548
-95.6%
0.00%
Q1 2016$50,000
-20.6%
12,397
+97.6%
0.00%
Q4 2015$63,000
-54.7%
6,273
-68.5%
0.00%
Q3 2015$139,000
-73.9%
19,919
+75.7%
0.00%
-100.0%
Q2 2015$532,000
+32.0%
11,335
+1.4%
0.00%
Q1 2015$403,000
-42.7%
11,174
-37.9%
0.00%
-100.0%
Q4 2014$703,000
+4921.4%
18,008
+2356.8%
0.00%
Q3 2014$14,000
+180.0%
733
+83.2%
0.00%
Q2 2014$5,000
-97.6%
400
-98.1%
0.00%
Q1 2014$207,000
+6800.0%
20,743
+6955.4%
0.00%
Q4 2013$3,000
-40.0%
294
-31.9%
0.00%
Q3 2013$5,000
+25.0%
432
-28.5%
0.00%
Q2 2013$4,0006040.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2019
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders